Trial intelligence / Profile preview

Efficacy and Safety of Ezetimibe Alone Versus Statin in Hypercholesterolemia

NCT00753883Phase 4Completed

Sponsor
Merck & Co.
Start
Jul 2006
Primary completion
May 2008
Modality
Small Molecules
01

Overview

A Phase 4 trial of ezetimibe in hypercholesterolemia, sponsored by Merck & Co.. Started Jul 2006; status: completed.

02

Drugs

ezetimibe
03

Conditions

hypercholesterolemia

Beyond the preview

Go deeper on NCT00753883.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00753883.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call